The high transforming potency of erbB-2 and ret is associated with phosphorylation of paxillin and a 23 kDa protein

Alfredo Romano, William T. Wong, Massimo Santoro, Peter J. Wirth, Snorri S. Thorgeirsson, Pier Paolo Di Fiore

Research output: Contribution to journalArticlepeer-review

Abstract

Two-dimensional gel maps of proteins phosphorylated by the epidermal growth factor receptor (EGFR) and erbB-2 kinases were obtained, to investigate the molecular basis of the different biological properties of these two molecules. Several proteins were phosphorylated by EGFR or erbB-2 with different stoichiometry. Differences were either quantitative or qualitative. In NIH3T3 cells, erbB-2 is 100-fold more transforming than EGFR. In the same cell line several proteins were preferentially phosphorylated by erbB-2, as compared to EGFR. To identify which of these substrates might be directly involved in mitogenic signaling, we obtained two-dimensional maps of proteins phosphorylated on tyrosine by EGFR/ret and an EGFR/erbB-2(TK) chimeric receptors. Both these chimerae behaved indistinguishably from erbB-2 in a number of bioassays and potently transformed NIH3T3 cells. Paxillin and a 23 kDa substrate were invariably phosphorylated to higher stoichiometry whenever potent mitogenic and transforming signals were activated. We propose that paxillin and the 23 kDa substrate are important elements in the erbB2 and ret-activated mitogenic and transforming signaling.

Original languageEnglish
Pages (from-to)2923-2933
Number of pages11
JournalOncogene
Volume9
Issue number10
Publication statusPublished - Oct 1994

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Fingerprint Dive into the research topics of 'The high transforming potency of erbB-2 and ret is associated with phosphorylation of paxillin and a 23 kDa protein'. Together they form a unique fingerprint.

Cite this